Cloghessy Paula has filed 8 insider transactions across 2 companies since February 2023.
Most recent transaction: a grant/award of 60000 shares of Kailera Therapeutics, Inc. ($KLRA) on April 16, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 16, 2026 | Kailera Therapeutics, Inc. | $KLRA | Cloghessy Paula | Chief People Officer | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Kailera Therapeutics, Inc. | $KLRA | Cloghessy Paula | Chief People Officer | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| April 27, 2023 | Seres Therapeutics, Inc. | $MCRB | Cloghessy Paula | See Remarks | A | Restricted Stock Units | 18835 | $0.00 | 18,835.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2023 | Seres Therapeutics, Inc. | $MCRB | Cloghessy Paula | See Remarks | M | Restricted Stock Units | 9418 | $0.00 | 9,417.0000 | 0 | 50.00% | 0.00% |
| Oct. 27, 2023 | Seres Therapeutics, Inc. | $MCRB | Cloghessy Paula | See Remarks | M | Common Stock | 9418 | $0.00 | 48,588.0000 | 0 | 24.04% | 0.00% |
| Oct. 30, 2023 | Seres Therapeutics, Inc. | $MCRB | Cloghessy Paula | See Remarks | S | Common Stock | 2904 | $1.35 | 45,684.0000 | 0 | 5.98% | 0.00% |
| Feb. 3, 2023 | Seres Therapeutics, Inc. | $MCRB | Cloghessy Paula | See Remarks | A | Stock Option (Right to Buy) | 95000 | $0.00 | 95,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2023 | Seres Therapeutics, Inc. | $MCRB | Cloghessy Paula | See Remarks | A | Restricted Stock Units | 47500 | $0.00 | 47,500.0000 | 0 | 9999.99% | 0.00% |